CCS
CAVM

Crosspoint Capital Strategies’s Cavium, Inc. CAVM Stock Holding History

Crosspoint Capital Strategies’s Portfolio CAVM Stock Details CAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6
Closed – – 1356
2015
Q3 		$0 Buy
+6
New +$400 ﹤0.01% 980

Other funds holding CAVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
abrdn Investment Management Edinburgh, United Kingdom $29.6B AUM 25.48% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Crosspoint Capital Strategies's CAVM Position: Q4 2015 in Review

Crosspoint Capital Strategies sold out of Cavium, Inc. (CAVM) in Q4 2015, closing a stake of 6 shares.

Crosspoint Capital Strategies first reported a position in CAVM in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 232 funds tracked by Wall St. Rank hold CAVM as of Q4 2015.

  • Crosspoint Capital Strategies reported no remaining Cavium, Inc. position as of Q4 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 6 Cavium, Inc. shares in Q4 2015.
  • Crosspoint Capital Strategies first reported a position in Cavium, Inc. in Q3 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Cavium, Inc. position peaked at $0 in Q3 2015.
  • 232 funds tracked by Wall St. Rank held Cavium, Inc. as of Q4 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2015, filed 16 Feb 2016.